Skip to main content
OpenTrials

Clinical trial condition

Non-Muscle Invasive Bladder Neoplasms

Explore clinical trials studying Non-Muscle Invasive Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

195 public trials 69 recruiting studies
Refine in advanced search Browse all conditions

Non-Muscle Invasive Bladder Neoplasms trial results

Completed

En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer

NCT05223491

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Department of Urology, Aalborg University Hospital Aalborg, Denmark
  • Department of Urology, Aarhus University Hospital Aarhus, Denmark
  • Department of Urology, Herlev Hospital Herlev, Denmark
  • Department of Urology, Regional Hospital Gødstrup Holstebro, Denmark
View Trial Details
Completed

A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

NCT05375903

Conditions
Bladder Cancer, Carcinoma, Carcinoma in Situ of Bladder, +18 more
Locations
  • Arkansas Urology Little Rock, Arkansas, United States
  • UCLA - University of California Los Angeles, California, United States
  • Florida Urology Partners, LLC Tampa, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 13 locations
View Trial Details
Completed

A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

NCT03914794

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
Locations
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins School of Medicine - Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Associated Medical Professionals Urology Syracuse, New York, United States
  • Midlantic Urology Bala-Cynwyd, Pennsylvania, United States
View Trial Details
Completed

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

NCT03081858

Conditions
Bladder Cancer, Bladder Cancer Cell Transitional, Carcinoma, +17 more
Locations
  • Urological Associates of Southern Arizona, PC Tucson, Arizona, United States
  • Trovare Clinical Research Bakersfield, California, United States
  • Tower Urology Los Angeles, California, United States
  • Chesapeake Urology Associates Hanover, Maryland, United States
View Trial Details
Completed

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

NCT05945108

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
Locations
  • Research Site Belo Horizonte, Brazil
  • Research Site Porto Alegre, Brazil
  • Research Site Recife, Brazil
  • Research Site Salvador, Brazil
View Trial Details
Completed

Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)

NCT05085990

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +14 more
Locations
  • USC Norris Cancer Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Tulane Medical Center (TMC) - Clinic/Outpatient Facility New Orleans, Louisiana, United States
  • Chesapeake Urology Research Associates Baltimore, Maryland, United States
View Trial Details
Completed

Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)

NCT05085977

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +14 more
Locations
  • USC Norris Cancer Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Tulane Medical Center New Orleans, Louisiana, United States
  • Chesapeake Urology Research Associates Baltimore, Maryland, United States
View all 14 locations
View Trial Details

Related conditions